Clinical Trials
Ascelia Pharma presents study showing comparable efficacy of Orviglance...
Ascelia Pharma AB is presenting a study in which Orviglance® (manganese chloride tetrahydrate, former working name Mangoral) was compared against a gadolinium-based contrast agent at...
Clinical Trials
Single Dose of Regen-Cov Provides Long-Term Protection Against COVID-19
Single dose of REGEN-COV (1,200 mg subcutaneous) reduced the risk of COVID-19 by 81.6% during the pre-specified follow-up period (months 2-8), maintaining the 81.4% risk...
Clinical Trials
Ferrer announces first patient enrollment of FNP122 in ADORE...
Ferrer, an international pharmaceutical company focused on neurological disorders and pulmonary vascular and interstitial lung diseases, has announced the next major milestone in its mission...
Clinical Trials
Antios Therapeutics and Assembly Biosciences Announce Clinical Collaboration
Antios Therapeutics, Inc. and Assembly Biosciences, Inc. announced that the companies have entered into a clinical collaboration agreement to evaluate a triple combination treatment in...
Clinical Trials
Moleculin obtains UK MHRA authorisation for Phase Ia trial...
Moleculin Biotech has obtained the UK Medicines and Healthcare Products Regulatory Agency (MHRA) authorisation to initiate a Phase Ia clinical trial of its drug, WP1122,...
Clinical Trials
Symbiosis Pharmaceutical Services Starts Producing Sevuparin for Modus Future...
Modus Therapeutics Holding AB , a company developing innovative treatments for patients with high unmet medical needs, announces that Symbiosis Pharmaceutical Services Ltd (“Symbiosis”), a...
Clinical Trials
Brii Bio Initiates Submission of EUA Filing to U.S....
Brii Biosciences Limited a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, announced the filing of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.